Abbott India Q2 profit rises 16% on higher sales, improved margins

Revenue from operations grew 7.7% to ₹1,757 crore, up from ₹1,633 crore a year earlier, the company said in its exchange filing. The healthcare major’s EBITDA rose 14.5% to ₹502.6 crore from ₹439 crore in the corresponding quarter last year.

Leave a Reply

Your email address will not be published. Required fields are marked *